HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis Nehmat HoussamiPetra MacaskillMark D. Pegram Review 23 June 2011 Pages: 659 - 674
Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis Zhen WangLiu-Cheng WuJun-Qiang Chen Review 09 July 2011 Pages: 675 - 689
Local anesthetics inhibit kinesin motility and microtentacle protrusions in human epithelial and breast tumor cells Jennifer R. YoonRebecca A. WhippleStuart S. Martin Preclinical study 11 November 2010 Pages: 691 - 701
Multicentric breast cancer: clonality and prognostic studies R. EelesG. KneeJ. Yarnold Preclinical study 16 November 2010 Pages: 703 - 716
Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma Kathryn C. BehlingAmy TangAgnieszka K. Witkiewicz Preclinical study 19 November 2010 Pages: 717 - 724
Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma Hermien HartogHugo M. HorlingsJelle Wesseling Preclinical study 24 November 2010 Pages: 725 - 736
SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer Kathryn A. ClausenKimberly R. BlishSuzy V. Torti Preclinical study 27 November 2010 Pages: 737 - 746
High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer Ida JohanssonCecilia NilssonIngrid Hedenfalk Preclinical study 27 November 2010 Pages: 747 - 760
Acquisition of metastatic tissue from patients with bone metastases from breast cancer J. F. HiltonE. AmirM. Clemons Preclinical study 27 November 2010 Pages: 761 - 765
Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs A. SmeetsA. DaemenM. R. Christiaens Preclinical study 30 November 2010 Pages: 767 - 776
Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2 Sreenivasan ParuthiyilAleksandra CvoroDale C. Leitman Preclinical study 01 December 2010 Pages: 777 - 784
Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance Andrew SkildumKenneth DornfeldKendall Wallace Preclinical study 03 December 2010 Pages: 785 - 797
Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work? Uwe GüthMary Elizabeth MyrickSeraina Margaretha Schmid Clinical Trial 13 July 2011 Pages: 799 - 807
Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations Soohyeon LeeHee Kyung AhnYoung-Hyuck Im Clinical Trial 23 July 2011 Pages: 809 - 817
A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer Suleiman MassarwehYee L. ThamRichard Elledge Clinical trial 27 July 2011 Pages: 819 - 827
First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study Kenjiro AogiNorikazu MasudaShigemitsu Takashima Clinical trial 31 July 2011 Pages: 829 - 838
The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures Yueyao DuQiong ZhouJinsong Lu Clinical Trial 02 August 2011 Pages: 839 - 848
Oncological and cosmetic outcome in breast cancer patients undergoing “moving window” operation Masakuni NoguchiMasafumi InokuchiTakeo Kosaka Clinical Trial 05 August 2011 Pages: 849 - 856
Excised and irradiated volumes in relation to the tumor size in breast-conserving therapy M. D. den HartoghB. van AsselenH. J. G. D. van den Bongard Clinical trial 06 August 2011 Pages: 857 - 865
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation Emilia MontagnaVincenzo BagnardiMarco Colleoni Clinical Trial 06 August 2011 Pages: 867 - 875
The association between chronic disease burden and quality of life among breast cancer survivors in Missouri Anjali D. DeshpandeJulianne A. SefkoMario Schootman Epidemiology 26 April 2011 Pages: 877 - 886
Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer Margaret M. MadeleineLisa G. JohnsonKathleen E. Malone Epidemiology 27 April 2011 Pages: 887 - 899
Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population Jing HanTao JiangHongbing Shen Epidemiology 28 April 2011 Pages: 901 - 907
The effect of system-level access factors on receipt of reconstruction among Latina and white women with DCIS Celia Patricia KaplanLeah S. KarlinerAnna Maria Nápoles Epidemiology 28 April 2011 Pages: 909 - 917
Well-done meat intake and meat-derived mutagen exposures in relation to breast cancer risk: the Nashville Breast Health Study Zhenming FuSandra L. DemingWei Zheng Epidemiology 03 May 2011 Pages: 919 - 928
Second events following ductal carcinoma in situ of the breast: a register-based cohort study Ragnhild Sørum FalkSolveig HofvindTor Haldorsen Epidemiology 03 May 2011 Pages: 929 - 938
A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families Atocha RomeroPedro Pérez-SeguraMiguel de la Hoya Epidemiology 03 May 2011 Pages: 939 - 946
Evidence for a link between TNFRSF11A and risk of breast cancer Núria BonifaciMarta PalafoxEva González-Suárez Epidemiology 04 May 2011 Pages: 947 - 954
Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study Wikke Setz-PelsLucien E. M. DuijmAdri C. Voogd Epidemiology 07 May 2011 Pages: 955 - 961
Second primary breast, endometrial, and ovarian cancers in Black and White breast cancer survivors over a 35-year time span: effect of age Hala H. Nsouli-MaktabiDonald E. HensonSean D. Cleary Epidemiology 08 May 2011 Pages: 963 - 969
Characterisation of unclassified variants in the BRCA1/2 genes with a putative effect on splicing Rita Dias BrandãoKees van RoozendaalMarinus J. Blok Brief Report 03 June 2011 Pages: 971 - 982
MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism Muhua YangYuan YaoQun Zhou Brief Report 03 June 2011 Pages: 983 - 991
The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in Europeans Thomas LangChristina JustenhovenHiltrud Brauch Brief Report 08 June 2011 Pages: 993 - 999
Effect of the overexpression of BRCA2 unclassified missense variants on spontaneous homologous recombination in human cells Cristina BaliaAlvaro GalliMaria Adelaide Caligo Brief Report 14 June 2011 Pages: 1001 - 1009
Data in a recent meta-analysis about TNF-alpha polymorphisms and breast cancer susceptibility need for clarification Min-Bin ChenJin-Hua GuRong-Min Gu Letter to the Editor 11 May 2011 Pages: 1011 - 1013
Associations between polymorphisms of tumor necrosis factor-α gene and breast cancer risk Chibo Liu Letter to the Editor 20 May 2011 Pages: 1015 - 1017
RAD51C germline mutations in Chinese women with familial breast cancer Zhiyuan PangLu YaoYuntao Xie Letter to the Editor 20 May 2011 Pages: 1019 - 1020
Regarding the article “The p160 ER co-regulators predict outcome in ER negative breast cancer” by Spears, Oesterreich, Migliaccio et al. published in Breast Cancer Res Treat, March 2011 Sara Alkner Letter to the Editor 20 May 2011 Pages: 1021 - 1021
Lack of association between hOGG1 Ser326Cys polymorphism and breast cancer susceptibility in European population Da-Peng DingYing ZhangXiao-Feng He Letter to the Editor 26 May 2011 Pages: 1023 - 1026
